Article info
PDFDTB select
Risk of secondary T-cell malignancy after CAR T-cell therapy
Citation
Risk of secondary T-cell malignancy after CAR T-cell therapy
Publication history
- First published June 3, 2025.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.